These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 10627897

  • 1. [Estimation of vaccination rates in children of 10 months, 2 years and 4 years of age who underwent a health checkup at the Well Child Clinic in Paris during the year 1997].
    Vincelet C, Bourgin C, Quinet B, Tabone MD.
    Arch Pediatr; 1999 Dec; 6(12):1271-8. PubMed ID: 10627897
    [Abstract] [Full Text] [Related]

  • 2. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM.
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [Abstract] [Full Text] [Related]

  • 3. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T, Forstén A, Desole MG, Ferrera G, Caubet M, Mesaros N, Boutriau D.
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [Abstract] [Full Text] [Related]

  • 4. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F, Knuf M, Heininger U, Jahn K, Collard A, Habermehl P, Schuerman L, Sänger R.
    Vaccine; 2004 Jun 02; 22(17-18):2226-33. PubMed ID: 15149781
    [Abstract] [Full Text] [Related]

  • 5. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Jun 02; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 6. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
    Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS.
    Pediatr Infect Dis J; 1997 Sep 02; 16(9):863-70. PubMed ID: 9306481
    [Abstract] [Full Text] [Related]

  • 7. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr 02; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 8. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
    Habermehl P, Leroux-Roels G, Sänger R, Mächler G, Boutriau D.
    Hum Vaccin; 2010 Aug 02; 6(8):640-51. PubMed ID: 20697200
    [Abstract] [Full Text] [Related]

  • 9. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H.
    Vaccine; 2011 Jul 18; 29(32):5130-6. PubMed ID: 21624412
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
    Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.
    Pediatr Infect Dis J; 2014 Jan 18; 33(1):73-80. PubMed ID: 24346596
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age.
    Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granström M, Blondeau C, Hoffenbach A.
    Pediatr Infect Dis J; 1998 Nov 18; 17(11):1026-33. PubMed ID: 9849987
    [Abstract] [Full Text] [Related]

  • 12. Immunization status of children enrolled in a hospital-based medicaid managed care practice: the importance of the timing of vaccine administration.
    Vivier PM, Alario AJ, Simon P, Flanagan P, O'Haire C, Peter G.
    Pediatr Infect Dis J; 1999 Sep 18; 18(9):783-8. PubMed ID: 10493338
    [Abstract] [Full Text] [Related]

  • 13. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?
    Usonis V, Bakasenas V.
    Eur J Pediatr; 1999 May 18; 158(5):398-402. PubMed ID: 10333123
    [Abstract] [Full Text] [Related]

  • 14. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U, DTP-HBV-IPV-059 Study Group, DTP-HBV-IPV-096 Study Group, Sänger R, Jacquet JM, Schuerman L.
    Vaccine; 2007 Jan 22; 25(6):1055-63. PubMed ID: 17049692
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul 22; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 16. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M, Crasta PD, Hardt K, Kovac M.
    Vaccine; 2015 May 28; 33(23):2727-33. PubMed ID: 24962750
    [Abstract] [Full Text] [Related]

  • 17. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005530. PubMed ID: 19588375
    [Abstract] [Full Text] [Related]

  • 18. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O.
    Hum Vaccin; 2010 Oct 08; 6(10):829-34. PubMed ID: 20864810
    [Abstract] [Full Text] [Related]

  • 19. Delays in the primary vaccination of children.
    Allard R, Guy M, Durand L, Hudon E, Robert Y.
    Can Med Assoc J; 1985 Jul 15; 133(2):108-10. PubMed ID: 3873983
    [Abstract] [Full Text] [Related]

  • 20. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
    Madhi SA, Koen A, Cutland C, Groome M, Santos-Lima E.
    Pediatr Infect Dis J; 2013 Aug 15; 32(8):889-97. PubMed ID: 23538523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.